ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 100 filers reported holding ALBIREO PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $544,572 | +22.9% | 25,200 | +10.0% | 0.00% | – |
| Q3 2022 | $443,000 | -2.6% | 22,900 | 0.0% | 0.00% | – |
| Q2 2022 | $455,000 | -33.4% | 22,900 | 0.0% | 0.00% | – |
| Q1 2022 | $683,000 | +28.6% | 22,900 | +0.4% | 0.00% | – |
| Q4 2021 | $531,000 | -25.3% | 22,800 | 0.0% | 0.00% | – |
| Q3 2021 | $711,000 | -11.3% | 22,800 | 0.0% | 0.00% | – |
| Q2 2021 | $802,000 | +9.4% | 22,800 | +9.6% | 0.00% | – |
| Q1 2021 | $733,000 | -6.0% | 20,800 | 0.0% | 0.00% | – |
| Q4 2020 | $780,000 | +3.4% | 20,800 | -8.0% | 0.00% | – |
| Q3 2020 | $754,000 | +84.8% | 22,600 | +46.8% | 0.00% | – |
| Q2 2020 | $408,000 | +120.5% | 15,400 | +36.3% | 0.00% | – |
| Q1 2020 | $185,000 | -10.2% | 11,300 | +76.6% | 0.00% | – |
| Q2 2019 | $206,000 | – | 6,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 270,146 | $6,627,000 | 3.42% |
| Perceptive Advisors | 1,704,330 | $39,506,000 | 1.50% |
| Birchview Capital, LP | 38,000 | $932,000 | 0.88% |
| SECTORAL ASSET MANAGEMENT INC | 229,978 | $5,641,000 | 0.77% |
| BVF INC/IL | 200,500 | $4,918,000 | 0.64% |
| Artal Group S.A. | 500,000 | $12,265,000 | 0.45% |
| PA Capital LLC | 14,692 | $360,000 | 0.38% |
| Chicago Capital, LLC | 180,911 | $4,438,000 | 0.36% |
| TPG Group Holdings (SBS) Advisors, Inc. | 716,381 | $17,573,000 | 0.28% |
| Fosun International Ltd | 197,005 | $4,492,000 | 0.27% |